Cytotoxic T cells react to cardiac peptides in patients with cancer that receive immunotherapy, resulting in myocarditis. Identifying the targets for T cells in patients who are immunosuppressed will enable a better understanding of individual risk before treatment is initiated
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation
Nature Communications Open Access 05 August 2024
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Johnson, D. B. et al. Nat. Rev. Clin. Oncol. 19, 254–267 (2022).
Wang, D. Y. et al. JAMA Oncol. 4, 1721–1728 (2018).
Axelrod, M. L. et al. Nature 611, 818–826 (2022).
Ribas, A. & Wolchok, D. J. Science 359, 1350–1355 (2018).
Wei, S. C. et al. Cancer Discov. 11, 614–625 (2021).
Johnson, D. B. et al. New Engl. J. Med. 375, 1749–1755 (2016).
Caforio, A. L. P. et al. Int. J. Cardiol. 179, 166–177 (2015).
Myers, J. M. et al. JCI Insight 1, e85851 (2016).
Gil-Cruz, C. et al. Science 366, 881–886 (2019).
Lv, H. et al. J. Clin. Invest. 121, 1561–1573 (2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wong, A., Epelman, S. Unchecked autoreactive CD8+ T cells wreak havoc in cancer immunotherapy. Nat Cardiovasc Res 1, 1111–1113 (2022). https://doi.org/10.1038/s44161-022-00184-9
Published:
Issue date:
DOI: https://doi.org/10.1038/s44161-022-00184-9
This article is cited by
-
Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation
Nature Communications (2024)